3EO Molecular Covid 19 Pharmacy Starter Package

SKU
3EO-BDL-COV19-CLPP
$359.00

PHARMACY STARTER PACKAGE INCLUDES BELOW:

  • 1 STARTER KIT
    • 1 Cube Reader 
    • 2 COVID-19 Test Keys
    • 2 Swabs 
    • 1 Quick Start guide 
    • 1 Power Adapter
  • 1 PACK OF 20 TEST KEYS
    • 20 COVID 19 Test Keys
    • 20 Swabs
    • 1 Product insert
  • ALSO INCLUDES:
    • Pharmacy Marketing Collateral for In Store promotion (including signage and poster)

In Stock! Ships Immediately!

The 3EO Health COVID-19 Test is a single-use test kit intended for the qualitative detection of nucleic acid from the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is for non-prescription home use or laboratory/professional use with self-collected Anterior Nasal (AN) swab specimens in individuals aged 14 years and older or individuals ≥ 2 years (collected by an adult) with symptoms of COVID-19. This test is similar to a PCR test in that it utilizes a molecular amplification technology for the detection of SARS-CoV-2 RNA. This viral RNA is generally detectable in AN swab specimen during the acute phase of infection. The 3EO Health COVID-19 Test, comprised of the 3EO “Swab” and reagent-containing 3EO “Key,” is to be used with the 3EO “Cube” (base unit / test reader) instrument.

  • GP: 30% (more margin for your team)
  • Technology: 3TR (Molecular)
  • Performance:
    • PPA: 95%
    • NPA: 100%
    • LoD: 733 copies / mL
  • Cost / Test: $18.95
    • 40 – 70% lower than current molecular
    • Under the elasticity price of $20 / test
  • Instrument life: ~8000+ cycles
  • Process: “Sample to Test”
  • Run time:
    • ~25 mins for a positive
    • ~30 mins for a negative
  • CPT Code: 87635 (Medicare $51.32)

For use under an Emergency Use Authorization (EUA) only.This product has not been FDA cleared or approved but has been authorized by the FDA under an Emergency Use Authorization (EUA) for OTC use.

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.